title: An in vitro assessment of fibroblast and osteoblast response to alendronate-modified titanium and the potential for decreasing fibrous encapsulation.
abstract: Fibrous encapsulation can impair implant osseointegration and cause implant failure but currently there are limited strategies to address this problem. Since bisphosphonates (BPs), a class of drugs widely used to treat bone diseases, was recently found to induce fibroblast apoptosis, we hypothesize that by loading BPs on titanium (Ti) implant surface, fibrous encapsulation may be inhibited with simultaneous enhancement of implant osseointegration. This strategy of local administration can also be expected to minimize the adverse side effects of BPs, which are associated with intravenous injections. To verify this hypothesis, alendronate was loaded on Ti surface via a hydroxyapatite (CaP) coating, and the effects of the loaded alendronate on fibroblast proliferation and apoptosis, and osteoblast proliferation, alkaline phosphatase (ALP) activity, and apoptosis were investigated in vitro. With a surface density of loaded alendronate 0.046 mg/cm(2) or higher, fibroblast proliferation was suppressed due to increased apoptosis, while osteoblast proliferation and ALP activity increased with minimal apoptosis. In a coculture of fibroblasts and osteoblasts in a 1:1 ratio, ~60% of the cells on these alendronate-loaded substrates were osteoblasts 1 day after cell seeding. The percentage of osteoblasts increased to about 75% 4 days after cell seeding. These results suggest that fibroblasts and osteoblasts respond differently toward the alendronate-modified substrates, and this phenomenon can potentially be capitalized to reduce fibrous encapsulation.
authors.affiliation: Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.
authors.forename: Xuefeng
authors.initials: X
authors.lastname: Hu
authors.forename: Koon Gee
authors.initials: KG
authors.lastname: Neoh
authors.forename: Zhilong
authors.initials: Z
authors.lastname: Shi
authors.forename: En-Tang
authors.initials: ET
authors.lastname: Kang
authors.forename: Wilson
authors.initials: W
authors.lastname: Wang
mesh_terms: D016475:3T3 Cells; D019386:Alendronate / Q000737:chemistry* / Q000494:pharmacology*; D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D050071:Bone Density Conservation Agents / Q000737:chemistry / Q000494:pharmacology*; D049109:Cell Proliferation / Q000187:drug effects; D017886:Durapatite / Q000737:chemistry; D005347:Fibroblasts / Q000166:cytology* / Q000187:drug effects; D051379:Mice; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects; D014025:Titanium / Q000737:chemistry*
chemical_list: D050071:Bone Density Conservation Agents; D017886:Durapatite; D014025:Titanium; D000469:Alkaline Phosphatase; D019386:Alendronate
references.citation: Biomaterials. 2009 Sep;30(26):4407-15
references.pmid: 19487022
references.citation: Clin Oral Investig. 2010 Feb;14(1):35-41
references.pmid: 19294435
references.citation: J Dent Res. 2010 Jan;89(1):40-5
references.pmid: 19948943
references.citation: J Biomed Mater Res A. 2003 Jan 1;64(1):38-47
references.pmid: 12483694
references.citation: Biomaterials. 2010 Oct;31(30):7776-84
references.pmid: 20643480
references.citation: J Invest Dermatol. 2007 Mar;127(3):526-37
references.pmid: 17299435
references.citation: J Cell Biochem. 1998 Feb 1;68(2):186-94
references.pmid: 9443074
references.citation: Tissue Eng Part B Rev. 2012 Oct;18(5):323-40
references.pmid: 22440082
references.citation: Biomaterials. 2009 Mar;30(9):1790-6
references.pmid: 19135249
references.citation: J Mater Sci Mater Med. 2010 Jul;21(7):2035-47
references.pmid: 20390323
references.citation: Am J Pathol. 2006 Jun;168(6):1793-807
references.pmid: 16723696
references.citation: FASEB J. 2011 May;25(5):1519-30
references.pmid: 21248240
references.citation: Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):133-8
references.pmid: 9874784
references.citation: J Clin Invest. 1997 Sep 15;100(6):1475-80
references.pmid: 9294113
references.citation: Bone. 2011 Jul;49(1):103-10
references.pmid: 21236370
references.citation: J Clin Invest. 1999 Nov;104(10):1363-74
references.pmid: 10562298
references.citation: Bone. 2005 Jan;36(1):52-60
references.pmid: 15664002
references.citation: Bone. 2006 May;38(5):617-27
references.pmid: 16046206
references.citation: J Immunol. 2004 Jul 15;173(2):1463-76
references.pmid: 15240743
references.citation: J Bone Miner Res. 2006 May;21(5):684-94
references.pmid: 16734383
references.citation: Mol Pharmacol. 2001 Feb;59(2):193-202
references.pmid: 11160853
references.citation: J Biomed Mater Res A. 2010 Aug;94(2):389-95
references.pmid: 20186735
references.citation: Lancet. 2007 Oct 27;370(9597):1508-19
references.pmid: 17964352
references.citation: Oral Dis. 2011 Mar;17(2):194-9
references.pmid: 20796232
references.citation: N Engl J Med. 2010 Nov 18;363(21):2027-35
references.pmid: 21083387
references.citation: Bone. 2012 May;50(5):1148-51
references.pmid: 22348981
references.citation: J Clin Invest. 1993 Dec;92(6):2577-86
references.pmid: 8254015
references.citation: J Dent Educ. 2003 Aug;67(8):932-49
references.pmid: 12959168
references.citation: Science. 2007 Aug 10;317(5839):807-10
references.pmid: 17690295
references.citation: Biomaterials. 2008 Mar;29(7):790-6
references.pmid: 18022226
references.citation: PLoS One. 2011;6(6):e21283
references.pmid: 21738629
references.citation: Biomaterials. 2005 Dec;26(34):6941-9
references.pmid: 16009417
references.citation: Nanomedicine. 2012 Apr;8(3):374-82
references.pmid: 21782779
references.citation: Biomaterials. 2010 Dec;31(34):8854-63
references.pmid: 20800276
references.citation: Cardiovasc Res. 2000 Feb;45(3):528-37
references.pmid: 10728374
references.citation: J Surg Res. 2012 Aug;176(2):484-9
references.pmid: 22099602
references.citation: JAMA. 2006 Jun 28;295(24):2833-6
references.pmid: 16804139
references.citation: Biomaterials. 2009 Oct;30(31):6168-77
references.pmid: 19692118
references.citation: J Support Oncol. 2007 Nov-Dec;5(10):475-82
references.pmid: 18240669
references.citation: J Orthop Res. 2005 May;23(3):511-9
references.pmid: 15885469
references.citation: Br J Haematol. 2009 Mar;144(5):667-76
references.pmid: 19036117
references.citation: Expert Opin Drug Deliv. 2011 Jan;8(1):113-26
references.pmid: 21174607
references.citation: Quintessence Int. 2005 Nov-Dec;36(10):759-69
references.pmid: 16261792
references.citation: J Oral Maxillofac Surg. 2012 May;70(5):1081-92
references.pmid: 21856057
references.citation: Br J Oral Maxillofac Surg. 2011 Jun;49(4):251-7
references.pmid: 20605289
references.citation: Biomaterials. 2008 Jun;29(17):2608-15
references.pmid: 18358527
references.citation: Trends Immunol. 2010 Mar;31(3):110-9
references.pmid: 20106721
references.citation: Cancer Res. 2000 Nov 1;60(21):6001-7
references.pmid: 11085520
references.citation: Am J Physiol Renal Physiol. 2011 Jan;300(1):F62-70
references.pmid: 20861083
references.citation: Biomaterials. 2001 Jun;22(12):1467-74
references.pmid: 11374445
references.citation: Int J Oral Maxillofac Implants. 2011 Jul-Aug;26(4):731-8
references.pmid: 21841981
references.citation: J Musculoskelet Neuronal Interact. 2009 Apr-Jun;9(2):61-71
references.pmid: 19516081
references.citation: Acta Biomater. 2011 Dec;7(12):4229-34
references.pmid: 21816237
references.citation: Stem Cells. 2007 Aug;25(8):2128-38
references.pmid: 17495112
references.citation: Arthritis Rheum. 2006 Oct;54(10):3221-32
references.pmid: 17009257
references.citation: Bone. 2011 Oct;49(4):710-6
references.pmid: 21807133
references.citation: Biomaterials. 2004 Aug;25(18):4105-15
references.pmid: 15046901
references.citation: Arch Oral Biol. 2011 May;56(5):491-8
references.pmid: 21146154
references.citation: J Biomed Mater Res A. 2006 Mar 15;76(4):826-34
references.pmid: 16345094
references.citation: J Bone Miner Res. 2010 Mar;25(3):606-16
references.pmid: 20422624
references.citation: J Control Release. 2009 Jan 19;133(2):90-5
references.pmid: 18848962